Johnson & Johnson today announced 12-month pilot-phase data from the OMNY-AF study, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation ...
Today, MAHA Center Inc. announced it will release a Super Bowl advertisement featuring Mike Tyson, simultaneously launching a national campaign for Americans to Eat Real Food. In the ad, Mike ...
Drinking coffee can increase lifespan and decrease risk of type 2 diabetes, liver disease, cardiovascular disease, ...
Global Intracardiac Echocardiography Market OverviewThe global intracardiac echocardiography (ICE) market is projected to grow at a CAGR of approximately 10% over the forecast period. This growth is ...
From detecting heart rhythm problems, to tracking breathing changes Apple devices are among the market leaders in the health ...
Atrial fibrillation, or A-fib, is becoming more common, but doctors say treatments are improving. The condition is a ...
3don MSN
Study finds 90 minutes weekly activity after ablation linked to fewer atrial fibrillation relapses
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...
New international research project AF-B-STEP will for the first time systematically assess how much time individuals spend in ...
Volta Medical, committed to revolutionizing care for underserved complex AF patients with breakthrough AI solutions, ...
New research from CU Anschutz scientists suggests that staying physically active after heart rhythm treatment may ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results